Information  X 
Enter a valid email address

Lifeline Scientific (LSI)

  Print      Mail a friend

Thursday 28 April, 2011

Lifeline Scientific

Notice of AGM

RNS Number : 5616F
Lifeline Scientific, Inc
28 April 2011
 

 

Lifeline Scientific, Inc.

("Lifeline" or "the Company")

 

AGM notice and document availability

 

Lifeline Scientific, the medical technology company focused on the worldwide commercialisation of its LifePort® Kidney Transporter, a product designed to address the global challenge of human donor organ shortages, announces that the Board has determined that the close of business of 2 May 2011 be fixed as the record date for the determination of shareholders entitled to vote at the Company's 2010 Annual Meeting of Shareholders to be held in Itasca, Illinois on 16 June 2011.

 

The Company anticipates announcing results for the year ended 31 December 2010 on Monday 9 May 2011.

 

On or before 13 May 2011, copies of the Company's Annual Report and Accounts for the year ended 31 December 2010 and Notice of the Annual Meeting will be posted to shareholders and will be available to view on the Company's website: www.lifeline-scientific.com

 

 

Enquiries:

 

Lifeline Scientific, Inc.

+ 1 847 294 0300

David Kravitz, CEO


Seymour Pierce

(Nominated Adviser and Broker)

+44 (0)20 7107 8000

Sarah Jacobs (Corporate Finance)


David Banks (Corporate Broking)


Financial Dynamics

+44 (0)20 7831 3113

Ben Brewerton / John Dineen


 

About the LifePort Kidney Transporter

Created with the challenges of organ recovery and transport in mind, LifePort Kidney Transporter is designed to provide improved kidney preservation, evaluation and transport prior to transplantation.  LifePort provides a sealed, sterile, protected environment where a solution is gently pumped through the kidney at cold temperatures to minimize damage while the organ is outside the body.  LifePort is lightweight and portable, allowing organs to be perfused from the time of recovery until transplant.  It is designed to travel unaccompanied by land or air, safely transporting the kidneys across town or between countries.  While the kidney is being perfused, the LifePort records data on temperature, flow rate vascular resistance and pressure every 10 seconds providing surgeons with additional data prior to transplant.    

 

About Lifeline Scientific Inc.

Lifeline Scientific, Inc. is a Chicago-based global medical technology company with European headquarters located in Brussels.  Its primary focus is to commercialise its FDA approved, CE marked, clinically validated and revenue generating LifePort Kidney Transporter. Devices for preservation of the heart, lung pancreas and liver are in late stage pre-clinical development.

 

For further information please see www.lifeline-scientific.com

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOADKODQNBKDDQB